Daklinza (daclatasvir)

pCPA File Number: 21085
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Hepatitis C
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: